Mottiwala Aziz

Insider CIK 1788542 · RXST President and CEO, Director · TARS Chief Commercial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RXST RxSight, Inc.	A Award deriv	2026-07-24	2026-07-24	571,286	—	$0	571,286	SEC↗
RXST RxSight, Inc.	A Award deriv	2026-07-24	2026-07-24	2,312,138	—	$0	2,312,138	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-19	2026-03-19	4,440	$67.00	$297.5K	61,480	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-18	2026-03-19	4,330	$68.71	$297.5K	65,920	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2026-03-17	2026-03-19	4,286	$69.42	$297.5K	70,250	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2026-03-15	2026-03-17	5,524	—	$0	16,574	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2026-03-15	2026-03-17	8,020	—	$0	16,040	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2026-03-15	2026-03-17	8,148	—	$0	8,148	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2026-03-15	2026-03-17	4,790	—	$0	0	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2026-03-15	2026-03-17	26,482	—	$0	74,536	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2026-03-05	2026-03-09	19,306	—	$0	19,306	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2026-03-05	2026-03-09	30,724	—	$0	30,724	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-06-09	2025-06-11	17,500	$43.76	$765.8K	47,557	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-03-20	2025-03-20	3,365	$50.11	$168.6K	65,057	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-03-19	2025-03-20	3,557	$47.40	$168.6K	68,422	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2025-03-18	2025-03-20	3,643	$46.29	$168.6K	71,979	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2025-03-15	2025-03-18	4,790	—	$0	4,790	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2025-03-15	2025-03-18	8,148	—	$0	16,296	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2025-03-15	2025-03-18	8,019	—	$0	24,060	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2025-03-15	2025-03-18	20,957	—	$0	75,622	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2025-03-05	2025-03-07	33,691	—	$0	33,691	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2025-03-05	2025-03-07	22,098	—	$0	22,098	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2024-03-18	2024-03-19	4,766	$30.60	$145.8K	54,075	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2024-03-15	2024-03-19	4,790	—	$0	9,580	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2024-03-15	2024-03-19	8,148	—	$0	24,444	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2024-03-15	2024-03-19	12,938	—	$0	58,841	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-03-07	2024-03-11	47,500	—	$0	47,500	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2024-03-07	2024-03-11	32,079	—	$0	32,079	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-07-19	2023-07-21	2,400	$20.05	$48.1K	45,806	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-06-08	2023-06-12	100	$20.00	$2.0K	48,086	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-06-07	2023-06-08	2,500	$19.34	$48.4K	48,186	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-06-06	2023-06-08	2,143	$18.61	$39.9K	50,686	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-23	2023-03-23	372	$12.15	$4.5K	52,829	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-22	2023-03-23	357	$12.64	$4.5K	53,201	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-21	2023-03-23	349	$12.89	$4.5K	53,558	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-20	2023-03-21	358	$12.61	$4.5K	53,907	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-17	2023-03-21	339	$13.28	$4.5K	54,265	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2023-03-16	2023-03-17	336	$13.43	$4.5K	54,604	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2023-03-15	2023-03-17	4,790	—	$0	14,370	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2023-03-15	2023-03-17	4,790	—	$0	54,940	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2023-03-08	2023-03-10	32,592	—	$0	32,592	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2023-03-08	2023-03-10	48,116	—	$0	48,116	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2022-11-15	2022-11-17	6,857	$17.72	$121.5K	49,729	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2022-08-24	2022-08-26	4,416	$10.99	$48.5K	10,573	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2022-08-24	2022-08-26	772	$0.45	$347	0	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2022-08-24	2022-08-26	4,416	$10.99	$48.5K	55,814	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2022-08-24	2022-08-26	772	$0.45	$347	56,586	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2022-03-09	2022-03-11	19,160	—	$0	19,160	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2022-03-09	2022-03-11	65,312	—	$0	65,312	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-11-08	2021-11-10	1,889	$28.11	$53.1K	50,203	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-11-05	2021-11-08	11	$28.11	$309	52,092	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-11-04	2021-11-08	100	$28.03	$2.8K	52,103	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-11-02	2021-11-04	542	$27.07	$14.7K	52,203	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-11-02	2021-11-04	5,458	$26.75	$146.0K	52,745	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2021-09-10	2021-09-14	2,593	$0.45	$1.2K	772	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise deriv	2021-09-10	2021-09-14	4,350	$10.99	$47.8K	14,989	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2021-09-10	2021-09-14	4,350	$10.99	$47.8K	58,203	SEC↗
TARS Tarsus Pharmaceuticals, In	S Sale	2021-09-10	2021-09-14	2,593	$22.15	$57.4K	58,203	SEC↗
TARS Tarsus Pharmaceuticals, In	M Exercise	2021-09-10	2021-09-14	2,593	$0.45	$1.2K	60,796	SEC↗
TARS Tarsus Pharmaceuticals, In	A Award deriv	2021-01-07	2021-01-08	40,999	—	$0	40,999	SEC↗